
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. is expected to experience substantial growth driven by improving yields, which accounted for approximately 25% of their annual growth in 2024 and are anticipated to continue increasing. Despite a current penetration rate of only 3.5% among eligible employees compared to the 9% rate of traditional physical therapy, the company's strategic tools, such as Hinge Connect, are designed to improve engagement and drive higher yields. Additionally, the company has demonstrated strong net revenue retention (NRR) rates of 116-117% over the past two years, suggesting robust customer loyalty and ongoing revenue growth potential.
Bears say
Hinge Health Inc's 2Q25 earnings report indicated an EBIT margin of 19%, yet management's guidance for mid-teens EBIT margins in the latter half of 2025 raises concerns about sustainable profitability moving forward. The projected consensus EBIT margins of 14.6% for FY26 and 16.2% for FY27 appear to be low, suggesting potential challenges in enhancing operational efficiency or managing costs. These outlook indicators may signal a troubling trajectory for the company's financial health and investor confidence.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares